These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 23206212

  • 1. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
    Tungol A, Starner CI, Gunderson BW, Schafer JA, Qiu Y, Gleason PP.
    J Manag Care Pharm; 2012; 18(9):690-700. PubMed ID: 23206212
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of Low-Cost Generic Program Use in a Nationally Representative Cohort of Privately Insured Adults.
    Pauly NJ, Brown JD.
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1162-70. PubMed ID: 26679965
    [Abstract] [Full Text] [Related]

  • 3. Comparison of mail-order with community pharmacy in plan sponsor cost and member cost in two large pharmacy benefit plans.
    Johnsrud M, Lawson KA, Shepherd MD.
    J Manag Care Pharm; 2007 Mar; 13(2):122-34. PubMed ID: 17330973
    [Abstract] [Full Text] [Related]

  • 4. Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.
    Khandelwal N, Duncan I, Rubinstein E, Ahmed T, Pegus C.
    J Manag Care Pharm; 2012 Apr; 18(3):247-55. PubMed ID: 22468733
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dalfampridine prior authorization program: a cohort study.
    Gleason PP, Phillips J, Fenrick BA, Delgado-Riley A, Starner CI.
    J Manag Care Pharm; 2013 Apr; 19(1):18-25. PubMed ID: 23383704
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Benefit restrictions and gout treatment.
    Wang SM, Aranda GA, Gao S, Patel BV.
    J Manag Care Pharm; 2013 Apr; 19(9):773-82. PubMed ID: 24156646
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Administrative claims analysis of utilization and costs of care in health plan members with atopic dermatitis who had prior use of a topical corticosteroid and who initiate therapy with pimecrolimus or tacrolimus.
    Delea TE, Gokhale M, Makin C, Hussein MA, Vanderpoel J, Sandman T, Chang J, Sung J, Pinkston P, Gause D, Jackson M.
    J Manag Care Pharm; 2007 May; 13(4):349-59. PubMed ID: 17506601
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT, Neill KK, Davis DA.
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.